Long-term efficacy and safety of osilodrostat in patients with Cushing’s disease: results from the LINC 4 study extension

Overview of attention for article published in Frontiers in endocrinology, August 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 4,871 followers.

New Research: Long-term efficacy and safety of osilodrostat in patients with Cushing’s disease: results from the LINC 4 study extension: Objective To evaluate the long-term efficacy and safety of osilodrostat in patients with… #Endocrinology #Endo https:/

23 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.